Start Free

Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-011 · synthetic case ANEM-FX-10

Hemoglobin fell from 13.2 to 9.8

A fall of 3.4 g/dL.

Synthetic · no real patientAuthored by Biod · reviewed by Dr. AmaralAnemia engine v1.0.0

Purpose: A fall of 3.4 g/dL.

Inputs the engine received

CBC and reticulocytes

Hemoglobin
9.8 g/dL
Hematocrit
30 %
MCV
90 fL
Reticulocytes
4 %
Prior hemoglobin
13.2 g/dL

Patient

Age
60 years
Sex
Male

What the engine reports

Detected clinical pattern

Urgent Review Finding

A safety rule calls for urgent clinical assessment. Read the safety findings first.

  • Severity: Moderate anemia (Hb 9.8 g/dL)
  • Morphology: Normocytic (MCV 80–100)
  • Marrow response: Marrow response inadequate (RPI 1.34)
  • Pattern: anemia blood loss pattern

Calculations

Corrected reticulocyte count
2.67%

Reticulocyte % × (hematocrit ÷ 45).

Reticulocyte production index
1.34

Corrected count ÷ maturation factor. 2 or more is an appropriate marrow response.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Assess for active bleeding or acute hemolysis.

Missing information

  • Ferritin (and transferrin saturation).
Evidence and rule trace · 7 rules

AN-CALC-01Derived values

Inputs: RPI 1.34

Derived values calculated.

AN-01Anemia present, with severity

Inputs: hemoglobin 9.8 g/dL (<13)

Anemia, moderate.

AN-02Morphology by MCV

Inputs: MCV 90 fL

Normocytic anemia.

AN-03Marrow response

Inputs: retic 4% · hematocrit 30% · RPI 1.34

Inadequate marrow response.

AN-15Blood-loss pattern

Inputs: reticulocyte response 1.34 · hemoglobin fell 3.4 g/dL

Pattern compatible with blood loss.

AN-SAFE-02Abrupt fall in hemoglobin

Inputs: hemoglobin 13.2 → 9.8 g/dL

Urgent: abrupt fall.

AN-MISS-01Information needed

Inputs: Ferritin

First-line studies are incomplete.

Evidence

  • EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
  • EV-TEFFERI-2003 · Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003;78(10):1274-1280.
  • EV-MENTZER-1973 · Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.

Physician adjudication required. Clinical decision support for physician review. This output classifies anemia by morphology and marrow response and lists patterns and safety considerations. It does not diagnose a cause, rank causes by probability, or select treatment or transfusion. Physician adjudication is required.

Change the values

The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.

Morphology

  1. ✓ Microcytic

    MCV <80 fL

  2. ● Normocytic

    MCV 80–100 fL

  3. ○ Macrocytic

    MCV >100 fL

Marrow response (reticulocyte production index)

  1. ● Inadequate · RPI <2

    Hypoproliferative: deficiency, inflammation, kidney, marrow

  2. ○ Appropriate · RPI ≥2

    Blood loss, hemolysis or recovery

CBC and reticulocytes
  • <7
  • 7–8
  • 8–11
  • 11–13
  • ≥13
Patient
Sex
Iron, vitamins and inflammation
Hemolysis, kidney and thyroid

250 U/L is assumed when empty.

Blood film and other context

Live result · computed in your browser

Detected clinical pattern

Urgent Review Finding

A safety rule calls for urgent clinical assessment. Read the safety findings first.

  • Severity: Moderate anemia (Hb 9.8 g/dL)
  • Morphology: Normocytic (MCV 80–100)
  • Marrow response: Marrow response inadequate (RPI 1.34)
  • Pattern: anemia blood loss pattern

Calculations

Corrected reticulocyte count
2.67%

Reticulocyte % × (hematocrit ÷ 45).

Reticulocyte production index
1.34

Corrected count ÷ maturation factor. 2 or more is an appropriate marrow response.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Assess for active bleeding or acute hemolysis.

Missing information

  • Ferritin (and transferrin saturation).
Evidence and rule trace · 7 rules

AN-CALC-01Derived values

Inputs: RPI 1.34

Derived values calculated.

AN-01Anemia present, with severity

Inputs: hemoglobin 9.8 g/dL (<13)

Anemia, moderate.

AN-02Morphology by MCV

Inputs: MCV 90 fL

Normocytic anemia.

AN-03Marrow response

Inputs: retic 4% · hematocrit 30% · RPI 1.34

Inadequate marrow response.

AN-15Blood-loss pattern

Inputs: reticulocyte response 1.34 · hemoglobin fell 3.4 g/dL

Pattern compatible with blood loss.

AN-SAFE-02Abrupt fall in hemoglobin

Inputs: hemoglobin 13.2 → 9.8 g/dL

Urgent: abrupt fall.

AN-MISS-01Information needed

Inputs: Ferritin

First-line studies are incomplete.

Evidence

  • EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
  • EV-TEFFERI-2003 · Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003;78(10):1274-1280.
  • EV-MENTZER-1973 · Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.

Physician adjudication required. Clinical decision support for physician review. This output classifies anemia by morphology and marrow response and lists patterns and safety considerations. It does not diagnose a cause, rank causes by probability, or select treatment or transfusion. Physician adjudication is required.

More anemia cases

ANEM-FX-01

Microcytic anemia with low ferritin

A 36-year-old, Hb 9.9, MCV 72, ferritin 6, TSAT 7%.

ANEM-FX-02

Microcytic anemia, normal iron indices and a low Mentzer index

MCV 62, RBC 5.7.

ANEM-FX-03

Macrocytic anemia with low B12 and hypersegmented neutrophils

MCV 112.

ANEM-FX-04

Hemolysis: reticulocytes 12%, LDH 640, haptoglobin 5

Spherocytes and a positive DAT.

ANEM-FX-05

Anemia in CKD

eGFR 28, normocytic, low reticulocytes, iron replete.

ANEM-FX-06

Anemia of inflammation

CRP 30, ferritin 340, TSAT 12%.

All anemia cases

Try Biod in your practice

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Start Free for 3 Months (opens in a new tab)Send us a message

Contact Biod